Multiple abstracts accepted featuring imdusiran clinical data – highlighting progress toward a potential functional cure for chronic hepatitis B virus AB-101 clinical data abstract recognized as a ...

Fruit Defenders is a classic tower defense game set in the One Piece universe. The game features every One Piece character, from villains to protagonists. With the banger anime music playing in the ...

Calcium is a star mineral in milk, yogurt and cheese, but many people don’t get enough of this nutrient important for strong bones. The Dietary Guidelines for Americans list calcium as one of the ...

Mangos, often dismissed as too sugary, may hold hidden benefits for those at risk of diabetes. A George Mason University study found that daily mango eaters showed better blood sugar control and less ...

In the forests of Uganda and Côte d'Ivoire, chimps crowd into fig and plum trees, feasting on fruit that's sweet, soft and just a little boozy. A new study shows those daily snacks quietly add up to ...

Arbutus Biopharma (ABUS) is a clinical-stage biotech focused on LNP technology, with value now hinging on ongoing patent litigation against Moderna and Pfizer/BioNTech. Recent management changes and ...

As the summer is coming to an end and autumn is upon us, perhaps many of us are realising that we have a lot of fruit flies around the house. Over time, they can be a nuisance as they progress from ...

Cynthia Sass is a nutritionist and registered dietitian with master's degrees in both nutrition science and public health. Frequently seen on national TV, she's Health's contributing nutrition editor ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Arbutus ...

Dragon fruit, a vibrant superfood packed with nutrients, offers numerous health benefits. However, excessive consumption may lead to digestive issues like bloating and gas. It can also affect blood ...

Arbutus Biopharma (ABUS) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.11 per share a year ago.

WARMINSTER, Pa., June 25, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease, ...